awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42417359-95FDF5C8-1770-41EE-844A-0DD86968B76D
Q42417359-95FDF5C8-1770-41EE-844A-0DD86968B76D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42417359-95FDF5C8-1770-41EE-844A-0DD86968B76D
The changing landscape of treatment options for metastatic castrate-resistant prostate cancer: challenges and solutions for physicians and patients.
P2860
Q42417359-95FDF5C8-1770-41EE-844A-0DD86968B76D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42417359-95FDF5C8-1770-41EE-844A-0DD86968B76D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
013498473cb054669e6065d6fa5c728a6d1fceaa
P2860
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.